hnRNP A1 and hnRNP F Modulate the Alternative Splicing of Exon 11 of the Insulin Receptor Gene by Talukdar, Indrani et al.
hnRNP A1 and hnRNP F Modulate the Alternative
Splicing of Exon 11 of the Insulin Receptor Gene
Indrani Talukdar
1,2.¤a, Supriya Sen
1,2., Rodolfo Urbano
1,2¤b, James Thompson
3, John R. Yates III
3,
Nicholas J. G. Webster
1,2*
1VA San Diego Healthcare System, San Diego, California, United States of America, 2Department of Medicine and the Biomedical Sciences Graduate Program, University
of California San Diego, La Jolla, California, United States of America, 3The Scripps Research Institute, Department of Cell Biology, La Jolla, California, United States of
America
Abstract
Exon 11 of the insulin receptor gene (INSR) is alternatively spliced in a developmentally and tissue-specific manner. Linker
scanning mutations in a 59 GA-rich enhancer in intron 10 identified AGGGA sequences that are important for enhancer
function. Using RNA-affinity purification and mass spectrometry, we identified hnRNP F and hnRNP A1 binding to these
AGGGA sites and also to similar motifs at the 39 end of the intron. The hnRNPs have opposite functional effects with hnRNP
F promoting and hnRNP A1 inhibiting exon 11 inclusion, and deletion of the GA-rich elements eliminates both effects. We
also observed specific binding of hnRNP A1 to the 59 splice site of intron 11. The SR protein SRSF1 (SF2/ASF) co-purified on
the GA-rich enhancer and, interestingly, also competes with hnRNP A1 for binding to the splice site. A point mutation -
3URC decreases hnRNP A1 binding, increases SRSF1 binding and renders the exon constitutive. Lastly, our data point to a
functional interaction between hnRNP F and SRSF1 as a mutant that eliminates SRSF1 binding to exon 11, or a SRSF1
knockdown, which prevents the stimulatory effect of hnRNP F over expression.
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Introduction
The insulin receptor (IR) is encoded by a single gene (INSR),
which is composed of 22 exons [1]. Among these 22 exons, the 36
nt long exon 11 of the INSR gene is alternatively spliced to give
two IR isoforms; IR-A which excludes exon 11 and IR-B which
includes exon 11. The relative expression of IR isoforms depends
on species, tissue-type, developmental stage and pathological
condition. While IR-A is widely expressed, IR-B has more limited
distribution, being expressed predominantly in insulin-sensitive
tissues, such as liver, muscle, adipocytes and kidney, suggesting a
metabolic role [2,3,4].
Splicing of pre-mRNA involves the excision of introns in the
primary gene transcript and ligation of the exons to form the
mRNA. This process occurs by the recognition of specific sequences
at the exon-intron boundaries by small nuclear ribonucleoproteins
or snRNPs [5,6]. Inclusion of individual exons can be enhanced or
silenced by the binding of specific splicing factors to the primary
RNA transcript. A family of serine-arginine rich proteins (SR
proteins) plays a crucial role in alternative splicing of mRNA by
binding to exonic and intronic sites to enhance exon recognition
and interacting with components of the U1 and U2 snRNPs to
facilitate their binding to the 59 and 39 splice sites [7,8,9,10,11].
Indeed we have previously published that SRSF3 (SRp20) and
SRSF1 (SF2/ASF) bind to sites within exon 11 of the INSR gene to
promote exon inclusion [12].
The heterogeneous nuclear ribonucleoproteins (hnRNPs) are a
family of related proteins that lack an SR domain [13]. All hnRNP
family proteins share structural homology with amino-terminal
RNA binding domains (RRMs or KHs) and a carboxy-terminal
glycine rich domain and bind to RNA in a cooperative manner.
The hnRNP-A/B subfamily acts predominantly as repressors, but
the hnRNP F/Hsubfamily can actas activators as well as repressors
[14]. One potential mechanism by which hnRNPs inhibit splicing
involves competition for RNA binding sites with SR proteins
[14,15,16,17] thus interfering with the recruitment of snRNPs, but
hnRNP proteins can inhibit splicing by additional mechanisms
[18,19]. Cooperative binding of hnRNPs to high-affinity sites can
also contribute to silencing by recruiting molecules of hnRNP to
lower affinity binding sites and displacing SR proteins [20].
Cooperative binding may also explain how some hnRNPs promote
splicing by multimerizing across introns and bringing the
consecutive exons in close proximity thus looping out very large
introns. This phenomenon allows U1 and U2 snRNPs to interact
across large introns which eventually facilitate the inclusion of the
alternatively spliced exon [21].
We previously demonstrated exonic and intronic regulatory
elements in the insulin receptor gene that regulate alternative
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exonic splicing enhancer elements to promote exon inclusion and
CELF1 (CUG-BP1), a CELF-family protein, inhibits exon
inclusion by binding to both exonic and intronic silencer elements
[12]. In this paper we identify hnRNP F and -A1 as additional
proteins that bind to intronic and exonic splicing regulatory
elements to antagonistically regulate the alternative splicing of
exon 11. hnRNP F binds to both ends of intron 10 resulting
inclusion of exon 11. hnRNP A1 binds similarly to intron 10 but
also binds to the 59splice site of intron 11 resulting in repression of
exon 11 inclusion. Moreover, the relative expression of hnRNP F
and A1 correlates with splicing of the endogenous INSR gene in
HepG2 and HEK293 cells.
Results
Consensus binding sites for hnRNP A1, -F/H are found at
the 59 GA-rich sequence in intron 10 of IR
A sixty nucleotide GA-rich element is located near the 59 end of
intron 10 of IR gene and deletion of this region decreases the
inclusion of exon 11 in an IR minigene [22] suggesting a potential
intronic enhancer element. A series of linker scanning mutants
(GA1-10) was created by inserting a BglII restriction site in
minigene hIR, which contains the entire 2.3 kb intron 10, to
localize this enhancer element. The same linker scanning mutations
were made in minigene hIRD1.9 containing an internal deletion of
1.9 kb in intron 10. We have previously shown that this deletion
increase exon incorporation [22]. A number of the mutants show
decreased incorporation of exon 11 suggesting that multiple
regulatory elements within the GA-rich region contribute to the
enhancer function (Figure 1). Mutants GA1, GA7 and GA10
decreased exon 11 inclusion significantly in minigene hIR and
mutants GA1 and GA7 decrease exon 11 inclusion in minigene
hIRD1.9. Comparison of the sequences in linker scanning mutants
GA1, 7 and 10 identified a common AGGGA motif. A similar motif
UGGGA is also found spanning mutants GA3 and 4 but neither
substitution altered exon inclusion significantly, possibly as each
substitution was only a partial mutation of the site. The triple G
elements identified by mutants GA1, 4 and 7 were labeled IE1
(intronicelement1),IE2and IE3,respectively, forsubsequent invitro
binding analysis.
hnRNP A1 and -F/H and SRSF1 bind to the G-rich
elements in intron 10
To identify proteins that recognize the repeated AGGGA motif,
we analyzed nuclear proteins that bind to IE3 and its mutant
IE3m (GA7). RNA oligos spanning the sequences IE3 and IE3m
were synthesized and coupled to adipic-acid dihydrazide beads.
These RNA templates were used to affinity purify proteins from
HeLa nuclear extracts. We used HeLa extracts rather than HepG2
extracts as the former can support in vitro splicing of the IR
mRNA. Proteins were eluted with increasing concentrations of
KCl and the affinity-selected proteins were characterized by
Mudpit mass spectrometry (Figure 2A). The most abundant
proteins showing specific binding to IE3 were hnRNP F and
hnRNP H1, followed by hnRNP H2 and hnRNP U (scaffold
attachment factor A) (Table 1 and Material S1). We also identified
other proteins that bound equally to IE3 and IE3m including
NONO/SFPQ, SRSF1, PTBP1, hnRNP L and hnRNP A1/A2.
NONO/SFPQ forms a heterodimer that binds polypyrimidine
tracts and interacts with PTBP1 to promote spliceosomal assembly
[23,24,25]. SRSF1 is a SR protein that promotes alternative exon
usage. This is intriguing as we have already published that SRSF1
promotes exon 11 inclusion by binding to an exonic enhancer
[12]. To validate the binding of the hnRNP proteins and SRSF1
to the predicted sequences, an in vitro RNA pull-down assay was
performed using synthetic RNAs spanning IE1, IE2, IE3 and the
IE1m (GA1), IE2m (GA4) and IE3m (GA7) mutants. The pull
Figure 1. A GA-rich sequence is located near the 59 region of intron 10 of INSR. A schematic diagram of minigenes hIR and hIRD1.9 is
shown. White boxes represent exon 10 and 12 and the black box represents exon 11. The intervening lines indicate the introns in between. Dotted
lines indicate deletions. Solid perpendicular lines in minigene hIR and hIRD1.9 demonstrate the boundary of the GA rich sequence. Sequences of GA
rich region and the series of linker scanning mutants (GA1-10) are shown below. The ratio of isoform IR-B that includes exon 11 to isoform IR-A that
excludes exon 11 (6 standard deviation) is given at the right hand site for minigene hIRD1.9 and hIR as well as the mutants, after transient
transfection into HepG2 cells. Asterisks indicate statistical significance (*p#0.05, ** p#0.01) vs. wild-type sequence for n=4 experiments. ND
represents not determined. IE1, IE2 and IE3 indicate the intron elements used for subsequent in vitro binding experiments.
doi:10.1371/journal.pone.0027869.g001
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then followed by western blot analysis using antibodies to hnRNP
A1, F, and H and SRSF1 (Figure 2B). Greater hnRNP F binding
was observed with IE3, than with IE1 and IE2, as this site contains
closely spaced GGG triplets, which have been shown to bind to
RRM1 and RRM2 of hnRNP F [26]. In contrast, hnRNP A1
bound to IE1 and IE2 but only weakly to IE3. Lastly, hnRNP H
and SRSF1 bound consistently to all templates. The pull down
assay was repeated with recombinant hnRNP A1 and hnRNP F
with similar results (data not shown). Summary of the results and
alignments to conserved hnRNP A1, hnRNP F and SRSF1
binding sites are indicated in Figure 2C. Inspection of intron 10 for
additional GA-rich sites revealed three such sites at the 39 end of
the intron. RNAs containing these sites (3-1, 3-2, 3-3) were also
used in the RNA-affinity pull-down assay and they were found to
bind hnRNP A1, hnRNP H and hnRNP F similar to the sites at
the 59 end of the intron. The binding data are summarized in
Figure 2D.
Over expression or knockdown of hnRNP A1 and hnRNP
F modulates inclusion of exon 11 of an IR minigene
To test whether hnRNP A1, -H, or -F can regulate exon 11
inclusion, we co-transfected HepG2 cells with the hIR minigene
and expression vectors for hnRNP A1, -F or -H. Analysis of exon 11
splicing of the minigene construct indicated that over expression of
hnRNP A1 significantly decreases and hnRNP F significantly
increases the inclusion of exon 11 (Figure 3A). Over-expression of
hnRNP H does not have any effect on exon 11 inclusion in HepG2
cells (Figure 3A). As hnRNP A1 and -F appeared to play opposite
roles in splicing of exon 11 despite binding to similar sequences, we
titrated the hnRNPA1andhnRNPF expression plasmidsonthe IR
minigene. Transfection of increasing amounts of hnRNP F
expression plasmid in face of a constant quantity of hnRNP A1
causes an increase in the inclusion of exon 11, compared to hnRNP
A1 alone (Figure 3B). Conversely, transfecting increasing amounts
of hnRNP A1 expression plasmid in the face of a constant quantity
of hnRNP F causes a dose-dependent decrease in the inclusion of
Figure 2. hnRNP A1 and -F/H and SRSF1 bind to G-rich motifs
in intron 10. Panel A: RNA-affinity purification of HeLa nuclear proteins
using templates IE3 or IE3m, which contains the GA7 mutation. Se-
quences of IE3 and IE3m are given at top. Bound proteins were washed
four times with 100 mM KCl and then eluted with increasing concen-
trations of KCl. Proteins from washes 1 and 4 and from the KCl elution
were separated on a 4–12% Bis-Tris gel andstained with Coomassie blue.
Arrowheads indicate differential protein bands between the two RNA
templates. Panel B: In vitro RNA pull-down assay using RNA templates
IE1, IE2 and IE3 and their cognate mutants. Bound proteins were
separated by gel electrophoresis and immunoblotted for hnRNP A1,
hnRNP H, hnRNP F or SRSF1. Panel C: Summary of binding to 59 GA-rich
motifs. The consensus binding sites for hnRNP F [34], hnRNP A1 [35], and
SRSF1 [36] are shown. Relative binding associated with the RNA is
indicated by plus signs. Minus signs denote no detectable binding. Panel
D: Summary of binding to 39 GA-rich motifs. The consensus binding sites
for hnRNP F and hnRNP A1 are shown. Relative binding associated with
the RNA is indicated by plus signs. Minus signs denote no detectable
binding.
doi:10.1371/journal.pone.0027869.g002
Table 1. Splicing factors bound to IE3 and its mutant by
Mudpit analysis.
Splicing Factors Calculated mass (Da) Spectrum count
IE3 IE3mut
Specific Binding
hnRNP H1 49229 355 140
hnRNP F 45672 162 93
hnRNP H2 49264 80 31
hnRNP U 90480 69 18
hnRNP H3 36926 22 0
Non-Specific Binding
NONO 54232 663 621
SFPQ 76150 424 526
SRSF1 27745 109 89
hnRNP A2/B1 37430 53 66
PTBP1 57221 42 60
hnRNP A1 38846 25 25
hnRNP L 60187 17 23
doi:10.1371/journal.pone.0027869.t001
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hnRNP A1 and hnRNP F were over-expressed by immunoblotting
(Figure 3C). Taken together, these data suggest that hnRNP F and
hnRNP A1 not only bind at multiple sites of intron 10, but also play
opposite roles in regulating exon 11 inclusion. This may provide an
explanation for the relatively small effect due to some linker
scanning mutations such as GA4 as binding of both hnRNP A1 and
hnRNP F is lost.
To further confirm the role of endogenous hnRNP F and -A1
on alternative splicing of exon 11, we used RNA interference to
knockdown the endogenous proteins. As expected, co-transfection
of the hIR minigene with siRNAs against hnRNP A1 and hnRNP
Figure 3. Over expression of hnRNP A1 decreases and hnRNP F increases inclusion of exon 11 of an INSR minigene, whereas
knockdown of endogenous hnRNP F and hnRNP A1 has the opposite effect. Panel A: Transient transfection of minigene hIR with the
expression vectors for hnRNP A1, F or H was performed in HepG2 cells. The relative expression level of the IR isoforms was measured by RT-PCR
analysis. For the control, minigene hIR was transfected with the empty expression vector. The graph indicates the ratio isoform B/isoform A
normalized to the value of minigene hIR alone and the values are mean 6 SD for n=5 experiments. A representative gel is shown. Asterisks indicate
significant changes in exon inclusion compared to the minigene hIR transfection alone (** p# 0.01). Panel B: Antagonistic effects of hnRNP A1 and F.
Minigene hIR was co-transfected with vector alone or with increasing amounts of hnRNP A1 or F (mg) keeping the amount of the other factor
constant. The graph indicates the ratio of isoform B/isoform A 6 standard deviation, and the values are normalized to the value of minigene hIR
alone for n=3 experiments. Asterisks indicate statistical significance vs. vector alone (* p# 0.05). Panel C: Over-expression of hnRNP A1 and hnRNP F
was tested by transient transfection of 0.5, 1 and 1.5 mg of the respective expression plasmids, followed by immuno-blot analysis. The increase in
expression level was compared with the non-transfected endogenous level. Panel D: siRNA against hnRNP F was co-transfected with minigene hIR in
HepG2 cells. Panel E: siRNA against hnRNP A1 was co-transfected with minigene hIR in HepG2 cells. Representative gels are shown. The graphs show
the quantification of isoform B/isoform A normalized to minigene hIR in the presence of the control siRNA (mean 6 SD, n=3). Asterisk indicates
statistical significance vs. control siRNA (*p#0.05). Panel F: Knockdown of hnRNP F and hnRNP A1 following siRNA transfection into HepG2 cells.
Panel G: Effect of hnRNP F knockdown on INSR gene splicing. Panel H: Effect of hnRNP A1 knockdown on INSR splicing. Representative gels are
shown. The graphs show the quantification of isoform B/isoform A (mean 6 SD, n=3).
doi:10.1371/journal.pone.0027869.g003
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expression experiments above. siRNA against hnRNP F signifi-
cantly decreases inclusion of exon 11 compared to the control
siRNA (Figure 3D) and co-transfection of siRNA against hnRNP
A1 significantly increases the inclusion of exon 11 (Figure 3E). We
then investigated the effect of the knockdown on the endogenous
INSR gene. The siRNAs reduced the level of hnRNP A1 or
hnRNP F proteins by immunoblotting (Figure 3F). The siRNA
against hnRNP F did not alter the splicing of the endogenous INSR
gene (Figure 3G) but knockdown of hnRNP A1 significantly
increased exon 11 incorporation in agreement with the minigene
result (Figure 3H). These results confirmed the ability of hnRNP
A1 to repress exon incorporation in both an artificial IR minigene
and also more importantly the endogenous INSR gene. The lack of
an effect of hnRNP F knockdown on the endogenous gene may
indicate that hnRNP F does not bind the endogenous RNA
transcript or may reflect a functional redundancy that is observed
on the endogenous gene that is absent on the simplified minigene.
Indeed, while the minigene mimics much of the regulation of the
endogenous gene, exon 11 incorporation is significantly less for the
endogenous gene perhaps suggesting additional negative regula-
tory factors.
Linker scanning mutants spanning of individual binding
sites do not disrupt the effects of hnRNP A1 and hnRNP F
As hnRNP A1 and hnRNP F bind to multiple sites within the
GA-rich enhancer in intron 10, we tested whether mutation of
individual binding sites would disrupt the effect of either protein
on exon 11 inclusion. Linker scanning mutants GA1, GA2, GA4
and GA7 were transfected with the expression vectors for hnRNP
A1 or -F (Figure 4A and 4B). Mutants GA1 and GA4 responded
partially to hnRNP A1, but GA7, where hnRNP A1 binds poorly,
and control mutant GA2, respond by decreasing exon 11 inclusion
similar to minigene hIR. Similar effects were seen with the GA
mutants in minigene hIRD1.9 (data not shown). In contrast,
hnRNP F increased exon 11 inclusion on all mutants comparable
to minigene hIR. These observations suggested redundant effects
through binding to multiple sites. To eliminate this redundancy,
we tested the deletion construct that lacks all the GA-rich binding
sites at the 59 end of the intron (minigene 59GAdel). Transfection
of this deletion mutant into HepG2 cells did not eliminate the
ability of hnRNP A1 to repress and hnRNP F to enhance exon 11
incorporation (Figure 4C). Since the linker scanning and deletion
mutations at the 59 end did not abolish the effect of hnRNP A1
and F, we looked at the other potential binding sites for these
proteins at the 39 end of intron 10. We deleted a 203 nucleotide
segment of intron 10 that contains the 39 GA-rich elements
(minigene 39GAdel). The deletion starts 95 nucleotides upstream
of exon 11 so does not interfere with the branch-point sequence or
39 splice site. As seen for the 59 sites, removal of the 39 binding sites
did not eliminate the effect of hnRNP A1 or hnRNP F on exon 11
incorporation (Figure 4C). Since neither the 59 nor the 39 deletions
eliminated the effect of hnRNP A1 or -F, we made a deletion
construct which eliminated both the 59 and 39 GA-rich binding
Figure 4. Linker scanning mutants do not disrupt the effect of hnRNP A1 or hnRNP F. Panels A and B: Co-transfection of linker scanning
mutants GA1, 2, 4 and 7 and minigene hIR with the expression vector for hnRNP A1 (Panel A) and hnRNP F (Panel B). Panel C: Schematic of the
deletion constructs spanning 59 (IE1, IE2 & IE3) or 39 (3-1, 3-2 & 3-3) binding sites (59GAdel and 39GAdel, respectively), or the combined 59/39GA
deletion construct, which lacks all GA-rich binding sites and the central 1.9 kb of the intron. Deletion mutants were co-transfected with hnRNP A1 or
hnRNP F in HepG2 cells. Total RNA was isolated 48h after co-transfection. The relative expression level of the IR isoforms was measured and analyzed
as described previously. The ratio of isoform B over isoform A of n=3 experiments with 6 SD is shown. Asterisks indicate statistical significance vs.
vector alone (* p#0.05, **p#0.01).
doi:10.1371/journal.pone.0027869.g004
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effectively eliminating all potential binding sites for hnRNP A1/F
in intron 10. Transfection of this complete deletion mutant into
HepG2 cells elevated exon 11 inclusion over the intact intron,
similar to minigene hIRD1.9 (Figure 1), but more importantly
eliminated the ability of both hnRNP A1 to decrease and hnRNP
F to increase exon inclusion (Figure 4C).
hnRNP A1 also binds at the junction of exon 11 and
intron 11 to repress exon 11 inclusion
Since hnRNP A1 and hnRNP F bind similar sequences and
have similar effects on splicing in other systems, we were curious
why these two factors have opposite effects on the INSR gene. We
noted that SRSF1 binds to the same intronic G-rich element as
hnRNP F and -A1, and we had shown previously that SRSF1 binds
exon 11 to promote inclusion [12], we wondered whether hnRNP
A1 or -F could also bind to the exon. On closer examination of the
SRSF1 binding site at the 39 end of exon 11, we noticed that the
adjacent exon 11-intron 11 junction (UAG|GUAAGA) resembles
an hnRNP A1 binding motif (UAGGGA). We tested whether
hnRNP F, A1 and H bind to this sequence using a synthetic RNA
spanning this splice site in an in vitro binding assay. We found
strong binding of hnRNP A1 and hnRNP H, but not hnRNP F, to
this RNA (Figure 5A). To disrupt the potential hnRNP A1 binding
site without altering the complementarity to the U1 snRNA, we
substituted the -3U with C (CAG mutant). Mutation of U to C at
this position decreases binding of hnRNP A1 but not hnRNP H or
U1-70K. We also noticed that binding of SRSF1 to this sequence
increases with the CAG mutation, which suggests steric competition
between hnRNP A1 and SRSF1 for binding to adjacent sites. The
competition was verified by measuring hnRNP A1 binding to exon
11 or to a mutant template (LS5) containing a linker scanning
mutation in the SRSF1 binding site (CGAGGA R AGATCT).
hnRNP A1 binding is greatly increased by the LS5 mutation
(Figure 5B). Transfection of the minigene carrying the splice site
CAG mutation drastically increases exon 11 incorporation and
eliminates the effect of hnRNP A1 to repress exon inclusion in
HepG2 cells (Figure 5C). In contrast CELF1 (CUG-BP1), another
negative regulator of INSR alternative splicing [12], still represses
exon 11 inclusion in the CAG mutant. This finding suggests the
inhibitory role for hnRNP A1 is due to binding at this splice site
rather than in the upstream intron.
Mutation of the SRSF1 binding site on exon 11 disrupts
the effect of hnRNP F on INSR splicing
As SRSF1 binding in intron 10 overlaps with hnRNP A1, -F
and -H binding, we wanted to test whether disruption of the
exonic SRSF1 binding site modulates the effect of hnRNPs on
INSR splicing. Surprisingly, mutation LS5, which eliminates the
ability of SRSF1 to promote exon inclusion [12], also eliminates
the ability of hnRNP F to increase exon 11 inclusion, whereas
disruption of the exonic SRSF3 binding site (LS2: CTCTTC R
AGATCT) has no effect (Fig. 6A). To confirm that hnRNP F
depends on SRSF1, we co-transfected cells with the expression
vector of hnRNP F along with siRNA against SRSF1 or against
SRSF3 as a control. The effect of hnRNP F to increase exon 11
incorporation is abolished in the SRSF1 knock-down cells
(Figure 6B) but not in the SRSF3 knock-down cells (Figure 6B).
These results suggest a functional interaction between hnRNP F
and SRSF1, but we were unable to detect physical interaction
between these two proteins by co-immunoprecipitation or by in
vitro pull-down assay with recombinant His-tagged hnRNP F (data
not shown).
Figure 5. hnRNP A1 but not hnRNP F binds at the junction of
exon 11 and intron 11 to repress exon inclusion. Panel A: The
nucleotide sequence of the RNA templates of the wild type exon 11/
intron 11 junction and the -3URC mutation (underlined). Binding sites
for SRSF1 and hnRNP A1 are indicated by bars above. Representative
blots show the results of in vitro RNA pull-down assays followed by
immunoblotting for hnRNP A1, F, H, and U1-70K and SRSF1. Panel B: The
nucleotide sequence of the RNA templates of the wild type exon 11 and
the LS5 mutation (underlined). Representative blots show the results of
in vitro RNA pull-down assays followed by immunoblotting for hnRNP A1
and SRSF1. Panel C: Transient transfection of the wild type minigene hIR
and the -3URC mutant in the absence and presence of the expression
vector of hnRNP A1 or CELF1. A representative gel is shown. The ratio of
isoform B over isoform A of n=3 experiments with 6 SD is shown.
Asterisks indicate statistical significance vs. wild type (** p# 0.01).
doi:10.1371/journal.pone.0027869.g005
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HEK293 cell lines and correlates with skipping of exon 11
To assess whether alterations of hnRNP A1 or -F might underlie
differential alternative splicing in HepG2 and HEK293 cells, we
measured endogenous splicing factor expression in these two cells.
As we have published previously, exon 11 inclusion is predominant
in HepG2 hepatoma cells (.70% inclusion) whereas exon 11 is
almost completely skipped (,10% inclusion) in HEK293 embry-
onic kidney cells [12]. Although hnRNP F and -H levels are
similar in these two cells, hnRNP A1 is expressed at a much higher
level in HEK293 cells (Figure 6C). Consistent with this obser-
vation, knockdown of hnRNP A1 in HEK293 cells causes a small
increase in exon 11 incorporation (B/A ratio 0.2160.04 for si-
hnRNP A1 vs. 0.1660.09 for si-ctrl, data not shown).
Discussion
We previously showed that alternative splicing of exon 11 of IR
gene is mediated through cis-acting sequences within intron 10
and we identified a GA-rich intronic splicing enhancer at the 59
end of intron 10. In this paper we localized the enhancer elements
within this region to a repetitive AGGGA motif using linker-
scanning mutagenesis. In vitro RNA binding assays and mass
spectrometry revealed that these G-rich motifs are binding sites for
the hnRNP proteins hnRNP A1, hnRNP H and hnRNP F, and
the SR protein SRSF1. The finding of SRSF1 binding to the
upstream intron is intriguing given our previous finding of SRSF1
binding to an exonic enhancer element to promote exon 11
inclusion. Co-transfection and knock-down studies indicated that
hnRNP A1 suppresses but hnRNP F enhances exon 11 incor-
poration. hnRNP H does not have any effect on IR minigene
splicing in HepG2 cells, which was somewhat surprising as hnRNP
H has been shown to repress exon 11 splicing in conjunction with
CELF1 in muscle cells [27]. This may be related to the observa-
tion that CELF1 is not expressed at a high level in HepG2 cells.
Furthermore we have found that hnRNP A1 protein is expressed
at a much higher level in HEK293 cells, where exon 11 is almost
completely excluded, than HepG2 cells where exon 11 is mostly
incorporated. This suggests that the relative ratio of hnRNP A1
and -F may play a role in determining the extent of exon 11
inclusion. hnRNP A1 is not be the only negative regulator of exon
11 inclusion in HEK293 cells however as knockdown only causes a
small increase in exon inclusion. These cells express high levels of
CELF1 that also represses exon inclusion, so the function of hnRNP
A1 and CELF1 to cause exon skipping may be redundant (12).
Mutation of the individual binding sites does not disrupt the effects
of hnRNP A1 and hnRNP F on exon 11 inclusion suggesting either
multiple redundant binding sites or alternative binding sites
elsewhere in the gene. Indeed, we found that these proteins also
bindto the 39 end of intron 10 but deletion of neither the 59 sites nor
the 39 sites by themselves could abolish the effect of hnRNP A1 or
hnRNP F. When all intronic binding sites were eliminated,
however, neither hnRNP A1 nor hnRNP F modulated exon 11
inclusion suggesting that binding of these proteins at both ends of
intron is required for their functional effect on INSR splicing.
Surprisingly, we also found that hnRNP A1, but not hnRNP F,
binds strongly to the exon 11-intron 11 junction. This suggested an
explanation for the functional difference between hnRNP A1 and
hnRNP F, in that binding of hnRNP A1 could impair recognition
of this splice site leading to exon skipping. The sequence of the
exon 11-intron 11 boundary of INSR gene is UAG|GUAUGA
(the consensus 59 splice site is MAG|GURRGU, M is A or C; R is
purine). This splice site resembles an hnRNP A1 binding motif
(UAGGGA). A search of the SpliceRack database shows that -3U
is only found in 2.5% of 59 splice sites (as opposed to 23% for the -
3C) suggesting evolutionary pressure to avoid this nucleotide so
that the splicing junction does not resemble an hnRNP A1 binding
site. We showed that a single URC mutation at the -3 position
disrupts the hnRNP A1 binding site homology without interrupt-
ing complementarity to the U1 snRNA, decreases hnRNP A1
binding, increases SRSF1 binding, and eliminates the effect of
hnRNP A1 on INSR splicing. The increase in SRSF1 binding and
Figure 6. Functional dependence of hnRNP F on SRSF1. Panel A: Co-transfection of wild-type and the linker scanning mutants LS2 or LS5 with
or without expression plasmid of hnRNP F. Sequence of the wild-type exon and the LS2 and LS5 mutants are shown underlined. Panel B: Co-
transfection analysis in HepG2 cells with or without the over expression of hnRNP F in the presence of siRNA against endogenous SRSF3(SRp20) or
SRSF1(SF2/ASF). Total RNA was isolated 48h after co-transfection. The relative expression level of the IR isoforms was measured and analyzed as
described previously. The ratio of isoform B over isoform A of n=3 experiments with 6 standard deviation is shown. Asterisks indicate statistical
significance vs. vector alone (* p# 0.05, **p# 0.01). Panel C: Total protein was extracted from HepG2 and HEK293 cells. Equal amounts of protein
were loaded and immunoblotted for hnRNP A1, F, H, or b-tubulin as a loading control. Graph shows relative expression normalized to b-tubulin.
doi:10.1371/journal.pone.0027869.g006
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for the exonic binding site between SRSF1 and hnRNP A1 to
antagonize INSR splicing. Interestingly, the elimination of the
exonic binding site for SRSF1 results in the complete disruption of
the hnRNP F effect, even though intronic hnRNP F and SRSF1
binding sites remain intact. This requirement was confirmed as
knock down of SRSF1, but not SRSF3, eliminated the effect of
hnRNP F over expression. More importantly, we showed that the -
3U RC mutation renders the exon constitutive. This observation
has important implications for alternative splicing. It is generally
thought that the splice sites associated with alternatively spliced
exons are weak and diverge from the consensus [28,29,30,31,32].
Much of this evidence is based on mutational analysis, where
increasing complementarity to the U1 snRNA increases splice site
usage. However, splice site prediction algorithms are not always
consistent with observed results. For example, the splice site score
for exon 11 is comparable with other constitutive exons in INSR.
Predictions of splice site strength using Markov and positional
weight matrix models for splice site scores indicate that exons 4-8
and exon 19 of INSR bear similar if not weaker splice sites, yet only
exon 11 is subject to alternative splicing. Our data suggest that
binding of a negative regulatory protein such as hnRNP A1 at a
splice junction can modulate the splice site strength and cause
skipping of the exon even if the splice junction sequence is
predicted to be strong. From the SpliceRack database, we
identified 75 genes that contain an exact match to exon 11 splice
site sequence (UAGGUAUGA). Interestingly, 64 of them (85%)
are alternatively spliced using the AStalavista (Alternative Splicing
transcriptional landscape visualization tool) web server. In contrast,
we identified 614 genesthat havean exactmatchto the -3Cexon 11
sequence (CAGGUAUGA) and 471 of them (77%) are alternatively
spliced. This suggests that -3 U splice sites are found in genes
undergoing alternative splicing at a greater frequency, with the
caveat that we do not know whether these exons themselves are the
site of alternative splicing. Our results suggest a model in which the
interaction between hnRNP A1 proteins across intron 10 and the
exon 11-intron 11 boundary causes skipping of exon 11. It would be
interesting to see whether a similar mechanismof alternative splicing
occurs in those 64 genes that contain the exact UAGGUAUGA
sequence at the splicing junction and further studies are planned to
test the generality of this model.
The overall mechanism of the regulation of INSR splicing by
various factors is complex. Binding of hnRNP A1 and hnRNP F to
both ends of the 2.3 kb intron 10 might be expected to increase
exon 11 inclusion, as Martinez-Contreras et al. have shown that
hnRNP binding to sites at both ends of an intron brings the two
ends together via protein-protein interactions, thus looping out the
intervening sequence and facilitating splicing [21]. The finding
that deletion of either the 59 or 39 binding sites does not abrogate
the ability of hnRNP F to increase exon inclusion, however, argues
against the looping model. One possible model is that the steric
competition between SRSF1 and hnRNP A1 at the exon 11-intron
11 junction determines whether the exon is recognized by the
splicing apparatus (Figure 7). If hnRNP A1 levels are high, then
hnRNP A1 binds to the splice site and intronic sequences thus
blocking both the 59 and 39 splice sites on exon 11. Indeed, Zhu
et al. have shown that hnRNP A1 binding is propagated along
RNA through co-operative binding interactions from an initial
high-affinity binding site [20]. In contrast if SRSF1 is high and
binds to the exon, hnRNP A1 is prevented from coating the exon
allowing other factors such as hnRNP F and SRSF3 to bind to
promote exon recognition. This would explain the dependence of
hnRNP F stimulation on the SRSF1 binding site in exon 11.
Whether this model holds for our system will require further
investigation.
Materials and Methods
Immobilization of RNA on agarose beads and RNA
binding assays
Synthetic RNAs were purchased from Integrated DNA
Technologies Inc (Coralville, IA). RNA affinity purification was
performedby modificationof a published procedure[33]. HeLa cell
nuclear extract was purchased from Accurate Chemical and
Scientific Corporation (Westbury, NY). Briefly, 1000 pmol of
RNA was oxidized with sodium m-periodate and covalently coupled
to 400 ml of 50% slurry of adipic acid dihydrazide-agarose beads
(Sigma, St. Louis, MO). The beads were washed three times with
2 M NaCl and then equilibrated with buffer D (20 mM HEPES-
KOH, pH 7.6, 10% (v/v) glycerol, 150 mM KCL, 0.2 mM EDTA
and 0.5 mM dithiothreitol) with 2.5mM ATP. RNA-agarose bead
slurry was incubated with 75 ml of HeLa nuclear extract under
splicing conditions at 30uC for 25 minutes in buffer D in a total
volume of 600 ml. The beads were washed five times with buffer D
then bound proteins were eluted by boiling in 60 ml of 2X protein
sample buffer. The affinity-selected proteins were separated by
electrophoresis on a 4–12% Bis-Tris gel (Bio-Rad Laboratories,
Hercules, CA) and analyzed by Western blotting. Sequences of
RNA templates are as follows: IE1-UUAGGGACCGAGAGG,
IE1m-UCACCACCCGAGAGG, IE2-GUAGUGGGACCCAG-
AGA, IE2m- GUACACGCACCCAGCGA, IE3-AGAAGGGU-
GGGUGGACUCUCAA, IE3m-AGAAGAUCUGGUGGACU-
CUCAA, IE4-CUGGGGAAGAUGUAGCUCACUCCGUCUA-
GCAAGUGAGGGAGCCAGUGG, WT- CGAGGACCCUAG-
GUAUGACUCACCUGUGCG, CAG- CGAGGACCCCAGG-
UAUGACUCACCUGUGCG. The sequence of the exon 11, LS2
and LS5 templates are as published [12].
Figure 7. Model for antagonistic regulation of exon 11
inclusion by hnRNP A1 and hnRNP F/SRSF1. When hnRNP A1 is
highly expressed compared to SRSF1, binding of hnRNP A1 to the 59
splice site of intron 11 and the intronic elements blocks recognition of
the exon by the splicing apparatus causing skipping of the exon. When
hnRNP A1 is low compared to SRSF1, binding of SRSF1 to the exon
prevents binding of hnRNP A1 allowing binding of SRSF3 and hnRNP F
that promote exon inclusion.
doi:10.1371/journal.pone.0027869.g007
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RNA affinity purification with the IE3 and the IE3m mutant
(GA7) RNA oligos was performed as above. After incubation with
Hela nuclear extract under splicing conditions, the RNA-agarose
beads were washed and then bound proteins were eluted with
increasing concentrations of KCl (250 mM, 500 mM,750 mM and
1 M). The eluents were precipitated with 2 volumes of chilled
acetone and centrifuged at 14,000 rpm for 10 minutes at 4uC. The
pellet was washed and dried. The RNA affinity purified proteins
wereanalyzed by4–20%SDS-PAGEelectrophoresis.The 500mM
fraction was analyzed by Mudpit, multidimensional chromato-
graphic separation coupled with tandem MS/MS (Material S1).
Plasmid constructs
The wild-type IR minigene (hIR) and a deleted mutant
(hIRD1.9) have been described previously [22]. Minigene hIR
contains the entire 2.3 kb intron 10 whereas minigene hIRD1.9
has a 1.9 kb deletion in the center of the intron. All other plasmids
were constructed using standard techniques. Linker-scanning
mutants were generated by PCR mutagenesis using the Quick-
change mutagenesis kit (Stratagene, La Jolla, CA). A BglII
restriction site was systematically inserted every six nucleotides
throughout the GA-rich enhancer in intron 10. Plasmids expressing
hnRNP F, hnRNP H and hnRNP A1 were purchased from ATCC
(Manassas, VA).
Cell culture, transfections and RNA extraction
HepG2, HeLa and HEK293 cells were obtained from A.T.C.C.
(Manassas, VA) and maintained routinely in minimum essential
medium plus. Earle’s salts (Invitrogen, Carlsbad, CA) with 10%
fetal bovine serum at 37uC under 10% CO2. Cells were plated at a
density of ,1610
6 cells/well in six-well plates. Medium was
changed every 2 days. Transfections were performed with Fugene-
6 (Roche, Indianapolis, IN) or Transfast (Promega, Madison, WI)
transfection reagents according to the manufacturer’s protocol.
Cells were harvested 48 h after transfection and total cellular RNA
was prepared using RNAzol B (Tel-Test Inc, Friendswood, TX).
Reverse transcription and amplification of cDNA
Total RNA (1mg) was reverse transcribed using oligo-dT
(Applied Biosystem, Foster City, CA). The endogenous and the
transfected minigene IR transcripts were amplified using primer
pairs as described previously [22] and reactions were visualized on
12% polyacrylamide gels after staining with ethidium bromide.
The white and black images were inverted and the splicing
products were quantified with Kodak Electrophoresis Documen-
tation and Analysis System (EDAS) 290.
siRNA transfections and analysis
Double-stranded, pre-annealed siRNA oligonucleotides against
hnRNP A1, SRSF1, SRSF3 (Santa Cruz Biotechnology, Santa
Cruz, CA), hnRNP F (Integrated DNA Technologies Inc) or a
control siRNA (Santa Cruz) were co-transfected in HepG2 cells
with the INSR minigene at 100 nM concentration with Fugene 6.
To assess the effect of the knockdown on the endogenous INSR
gene, hnRNP A1 and F ‘on target plus, smartpool’ siRNAs were
purchased from Dharmacon and were tranfected into HepG2 cells
using Lipofectamine 2000 (Invitrogen, CA), using the manufac-
turer’s protocol. Forty-eight hours after transfection, cells were
harvested and assayed for mRNA expression. Relative expression
levels of isoform B and isoform A of the IR minigene were
measured as described before.
Whole cell lysate and western blot analysis
Whole cell lysates were prepared from HepG2 and HEK293
cells by using boiled lysis buffer (10 mM Tris, 1% SDS). Protein
concentration was measured using DC protein assay kit (Bio-Rad).
Equal amounts of protein were separated on 4–12% Bis-Tris gels
and immunoblotted with antibodies against hnRNP A1, -F, -H,
SRSF1 and beta-tubulin (Santa Cruz Biotechnology).
Supporting Information
Material S1 Mass spectrometry analysis following RNA
affinity purification. MudPIT Mass Spectrometry data for IE3
(Sample: wt1) starting on page 2 and for IE3 mutant (Sample: m1)
on page 19. Columns show the protein symbol, protein
description, number of peptide sequences, number of spectra,
sequence coverage, and molecular weight of protein.
(PDF)
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